Aluminum and Other Chemical Elements in Parenteral Nutrition Components and All-in-One Admixtures

• Published in: Clinical nutrition (Edinburgh, Scotland) Scotland), 2023-12, Vol.42 (12), p.2475-2483
• Main Authors: Schönenberger, Katja A., Saxer, Christoph, Neyer, Peter J., Huwiler, Valentina V., Reber, Emilie, Hammerer-Lercher, Angelika, Stanga, Zeno, Mühlebach, Stefan
• Format: Article
• Language: English
• Subjects: Adult; Aluminum; antimony; arsenic; atomic absorption spectrometry; cadmium; chromium; clinical nutrition; cobalt; Copper; Humans; Inductively coupled plasma mass spectrometry (ICP-MS); iron; kinetic energy; magnesium; manganese; Manganese - analysis; molybdenum; nickel; parenteral feeding; Parenteral Nutrition; Safety; selenium; standard deviation; tin; Toxicity; Trace elements; Trace Elements - analysis; vanadium; zinc
• ISSN: 0261-5614; 1532-1983
• DOI: 10.1016/j.clnu.2023.10.012

Parenteral nutrition (PN) can lead to high or even toxic exposure to aluminum (Al). We aimed to quantify concentrations of Al and other chemical elements of all-in-one (AIO) PN admixtures for adults prepared from commercial multichamber bags (Olimel® 5.7%, Omegaflex® special, SmofKabiven®, all with and without electrolytes) and vitamin and trace element additives over a 48-hour period. Secondly, we determined the level of Al contamination resulting from admixing and infusion set use. We used dynamic reaction cell and kinetic energy discrimination inductively coupled plasma mass spectrometry (ICP-MS) to quantify Al, arsenic (As), cadmium (Cd), cobalt (Co), chromium (Cr), copper (Cu), iron (Fe), magnesium (Mg), manganese (Mn), molybdenum (Mo), nickel (Ni), antimony (Sb), selenium (Se), tin (Sn), vanadium (V), and zinc (Zn) in AIO PN admixtures. We extracted samples for analysis via the bag injection ports and infusion sets over a 48-hour period after admixing. We compared the measured Al concentrations of AIO PN admixtures with calculated values based on the measured concentrations of individual chamber contents and additives. Mean (standard deviation) baseline Al concentrations in AIO PN admixtures ranged from 10.5 (0.5) to 59.3 (11.4) μg/L and decreased slightly over the 48 hours (estimate [standard error] -0.09 [0.02] μg/L/hour, p < 0.001). Thus, certain products exceeded the widely accepted limit of 25 μg/L. There was no significant difference in Al concentrations between samples extracted via the bag injection ports or infusion sets (p = 0.33), nor between measured and calculated Al concentrations of AIO PN admixtures (p = 0.91). Because certain commercially available PN admixtures for adults proved to contain excessively high levels of Al in our study, regulations and corresponding quality requirements at the authority level (e.g., Pharmacopoeia and regulatory authorities) are urgently required. Our results showed that the PN handling process (admixing and supplementing additives) or the materials of the infusion set did not lead to additional Al contamination to any extent. Moreover, calculated Al concentrations of AIO PN admixtures derived from individual chamber contents and additives are valid.